Hemas Holdings PLC has appointed Sabrina Esufally as an Executive Director to its Board, with effect from 1 July 2026.
Esufally is the Managing Director of Hemas Consumer Brands and a member of the Hemas Group Board of Management. The appointment adds her commercial and consumer sector experience to the company’s Board as Hemas continues to expand its presence in frontier markets.
She joined the Hemas Group in 2019 and has held leadership roles across pharmaceutical manufacturing, business development, innovation and consumer brands.
Since taking over the leadership of Hemas Consumer Brands, Esufally has overseen one of the Group’s strategically important businesses, expanding into new consumer segments through innovation while growing its portfolio of established brands.
Before joining Hemas, Esufally served as Head of Legal Research at Verité Research, where she specialised in governance and public policy.
She is an Attorney-at-Law of the Supreme Court of Sri Lanka. She holds a First Class Honours degree from the University of Durham, an LL.M. from Harvard Law School, and is an alumna of Harvard Business School.
Last modified: July 3, 2026




